|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-12-17
|
|
pubmed:abstractText |
The treatment of immune-mediated hemolytic anemia (IHA) complicating hematopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T- and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0001-5792
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
43-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12486323-Anemia, Hemolytic, Autoimmune,
pubmed-meshheading:12486323-Antibodies, Monoclonal,
pubmed-meshheading:12486323-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:12486323-Antigens, CD19,
pubmed-meshheading:12486323-B-Lymphocytes,
pubmed-meshheading:12486323-Female,
pubmed-meshheading:12486323-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:12486323-Hemoglobins,
pubmed-meshheading:12486323-Humans,
pubmed-meshheading:12486323-Infant,
pubmed-meshheading:12486323-Lymphocyte Depletion,
pubmed-meshheading:12486323-Mucopolysaccharidosis I,
pubmed-meshheading:12486323-T-Lymphocytes,
pubmed-meshheading:12486323-Transplantation, Homologous,
pubmed-meshheading:12486323-Transplantation Chimera,
pubmed-meshheading:12486323-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.
|
|
pubmed:affiliation |
Centro Trapianto di Midollo Osseo, Clinica Pediatrica dell'Università di Milano-Bicocca, Italia.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
